- International experts have issued a consensus statement recommending quick, targeted MRI scans for prostate cancer screening to reduce overdiagnosis and unnecessary biopsies.
- The recommendations, developed by Imperial College London researchers, suggest rapid MRI scans (under 15 minutes) for men aged 50-70, or from 45 for black men, preceded by PSA tests.
- These guidelines aim to standardise protocols for future screening programmes and will inform Prostate Cancer UK's Transform trial, which investigates promising screening techniques.
- The UK National Screening Committee (UKNSC) previously advised against routine population-wide prostate cancer screening using PSA tests, citing concerns about overdiagnosis and potential harm.
- A separate study presented at the same congress demonstrated that a risk-based approach could significantly reduce MRI referrals for prostate cancer by up to 60 per cent.
IN FULL